Form 4 holding
SVP & Chief Commercial Officer
Celldex Therapeutics, Inc.
- Security class
- ISO (right to buy)
- Shares / value
- 100,000
- Estimated value
- Report date
- 10 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount